EUVIMEDEUVIMED entdecken
Crossref

COVID-19 Vaccinations, SARS-CoV-2 Infections, and Type 1 Diabetes in Finnish Children

Susanna Tall iD, Jenni Pettersson, Taina Härkönen, Suvi M Virtanen, Olli Vapalahti, Mikael Knip

Diabetes Care · 01.07.2026 · 49 (7) · 1237-1245

DOI: 10.2337/dc25-2913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 05.05.2026. Verfasst von Susanna Tall und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, COVID-19, COVID-19 Vaccines, Vaccination. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Helsinki University Hospital (State Research Funding), Jane & Aatos Erkko Foundation, Medicinska.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE We assessed whether 1) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is associated with the risk of type 1 diabetes and 2) SARS-CoV-2 vaccination or infection is associated with disease severity at type 1 diabetes diagnosis. RESEARCH DESIGN AND METHODS Every Finnish child aged 5–14 years diagnosed with type 1 diabetes (case subjects, n = 433) during a 16-month period (September 2021 to December 2022) were compared with three control subjects matched for age, sex, and municipality. Information on coronavirus disease 2019 (COVID-19) vaccinations was obtained from the National Vaccination Register. SARS-CoV-2 infections were identified based on circulating antibody titer in samples obtained soon after the diagnosis of type 1 diabetes. RESULTS COVID-19 vaccinations preceding type 1 diabetes diagnosis were not associated with risk of type 1 diabetes (hazard ratio 1.30, 95% CI 0.97–1.72, P = 0.076). Vaccinations were linked to less severe symptoms at the time of diagnosis. Children with protective HLA genotypes were more common among the vaccinated case subjects compared with unvaccinated case subjects. Vaccinations were inversely associated with insulin autoantibody positivity. There was no association between SARS-CoV-2 and type 1 diabetes symptoms or autoantibodies at the time of type 1 diabetes diagnosis. CONCLUSIONS There was no significant association between SARS-CoV-2 vaccination and risk of type 1 diabetes. Neither COVID-19 vaccinations nor SARS-CoV-2 infections explain the more severe symptoms at type 1 diabetes diagnosis observed in Finnish children after the beginning of the COVID-19 pandemic. Parents who vaccinate their children are more likely to seek medical care. This may result in less severe symptoms in their children at diagnosis of diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1COVID-19COVID-19 VaccinesVaccinationHumansFinlandChildFemaleChild, PreschoolAdolescentMaleSARS-CoV-2Case-Control Studies

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Finnish Institute for Health and Welfare, Department of Public Health, Helsinki, Finland.
  • Department of Virology, Medicum, University of Helsinki, Helsinki, Finland.
  • Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
  • Center for Child, Adolescent and Maternal Health Research, Tampere University and Tampere University Hospital, Tampere, Finland.
  • Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.

ORCID-Profile: Susanna Tall

Förderung

  • Helsinki University Hospital (State Research Funding)
  • Jane & Aatos Erkko Foundation
  • Medicinska
  • Liv och Hälsa
  • Foundation for Pediatric Research in Finland
  • Helsinki University Hospital Research Funds
  • University of Helsinki Doctoral School (UHDS)
  • EU

Zitieren

APA

Tall, S., Pettersson, J., Härkönen, T., Virtanen, S. M., Vapalahti, O., & Knip, M. (2026). COVID-19 Vaccinations, SARS-CoV-2 Infections, and Type 1 Diabetes in Finnish Children. Diabetes Care, 49(7), 1237-1245. https://doi.org/10.2337/dc25-2913

Vancouver

Tall S, Pettersson J, Härkönen T, Virtanen SM, Vapalahti O, Knip M. COVID-19 Vaccinations, SARS-CoV-2 Infections, and Type 1 Diabetes in Finnish Children. Diabetes Care. 2026;49(7):1237-1245. doi:10.2337/dc25-2913

BibTeX
@article{Tall2026,
  author = {Tall, Susanna and Pettersson, Jenni and Härkönen, Taina and Virtanen, Suvi M and Vapalahti, Olli and Knip, Mikael},
  title = {COVID-19 Vaccinations, SARS-CoV-2 Infections, and Type 1 Diabetes in Finnish Children},
  journal = {Diabetes Care},
  year = {2026},
  volume = {49},
  number = {7},
  pages = {1237--1245},
  doi = {10.2337/dc25-2913}
}
Kostenlos starten →